Login / Signup

BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept.

Shaozhe CaiZi-Wei HuYu ChenYuxue ChenBingxia MingRongfen GaoZhen LiCong YeJi-Xin ZhongLingli Dong
Published in: Annals of the rheumatic diseases (2023)
Keyphrases
  • clinical trial
  • phase ii
  • double blind
  • study protocol
  • phase iii
  • randomized controlled trial